An Act relative to APOL1 mediated kidney disease
This bill (HD 4166) requires Massachusetts' Department of Public Health to study APOL1 gene variants linked to higher kidney disease risk. The department must issue a report by December 2026 with recommendations to increase awareness, screening, and genetic testing for these variants, plus analysis of funding strategies. The report will specifically address how to improve access to screening for Massachusetts residents affected by this genetic risk. It does not create new programs or funding but mandates a review to inform future health initiatives.
Bill status
Introduction
0 of 4 stages cleared
Introduction
Committee Review
Floor Vote
Governor
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
No actions recorded for this bill.
0 primary · 4 co-sponsors
Sponsors
No sponsor information available.
Ask Maddy
·
AI policy assistant
Ask Maddy about HD 4166
Scope: MA
Hi! I can help you understand HD 4166. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline